Copper is a ubiquitous trace metal necessary for normal function of a variety of cellular proteins.
ATPase7A. 13, 42, 71 Metallothionein is a low molecular weight cytoplasmic protein, ubiquitous among all tissues. It is synthesized in response to heavy metals (including copper), various hormones, and physiological factors such as stress. 10 An increase in cytoplasmic MT in the enterocyte results in decreased copper entering the blood. 42 The other protein known to have a role in copper metabolism in the enterocyte is ATPase7A. 13, 39, 71 Transmembrane cation ATPases have been shown as a common transmembrane copper transporter in a variety of cell types. 2, 39 ATPase7A is the copper transport protein that was shown to be defective in people with X-linked Menkes' disease and the animal model of Menkes' disease, the mottled mouse. 13, 71 In affected individuals, the defective ATPase7A results in faulty copper transport out of the enterocyte. The ATPase7A gene is widely expressed among the tissues of the body, and the defective protein results in copper accumulation in the enterocytes, among other tissues. However, the liver and brain, which have little or no expression of the gene, suffer copper deficiency. 13, 71 Therefore, in normal individuals, at least within the enterocyte, ATPase7A is one gate that serves to regulate copper entering the blood. Even though the enterocyte is known to regulate copper absorption, experimental studies in normal animals have clearly shown that chronic loading with high dietary copper can result in hepatic copper accumulation. 1, 19, 45, 56 Upon leaving the enterocyte, copper enters the blood. Serum copper in normal dogs is in the range of 0.4 g/ml (0.4 parts per million), which is about onethird that found in humans. 46 The serum copper (in all species) exists in two pools. One pool is loosely bound to carrier molecules (exchangeable pool), whereas the other is tightly bound. The exchangeable pool is the copper en route to the liver. The exchangeable copper in dogs is primarily bound to transcuperin (80%), with the rest bound to albumin and other low molecular weight molecules. The tightly bound copper largely represents that copper exported from the liver in the form of ceruloplasmin. In canine serum, about 42% of the copper is bound to ceruloplasmin, 42% to transcuperin, and 9% to albumin. 46 The liver is the major organ of copper uptake in dogs after both injection and oral ingestion. 20 Copper that is taken up by hepatocytes may follow one of several intracellular metabolic pathways. It may be incorporated into ceruloplasmin and returned to the circulation for transport to extrahepatic tissues. Second, hepatic copper may be incorporated into cuproenzymes occurring in the cytoplasm, such as superoxide dismutase, or into enzymes of membrane-bound organelles such as cytochrome c in the mitochondria. Third, the copper may be stored within the hepatocyte as copper MT. Finally, the hepatocyte copper may be excreted into the bile. 43 Interestingly, model copper transport systems identified in lower organisms indicate that each of these various metabolic routes may be carried out by a series of novel, specific transport molecules or specific copper chaperones. 2, 39 Copper is secreted from the hepatocyte in the form of ceruloplasmin, a 132,000-dalton glycoprotein. The apoprotein is synthesized in the cytomembrane system of the hepatocyte, and cytoplasmic copper is transported into the cytomembrane system via a cation transport ATPase (ATPase7B). The copper is incorporated into the apoprotein within the cytomembrane system prior to secretion by the hepatocyte. ATPase7B is the protein that is defective in people with Wilson's disease and the animal models, the Long-Evans Cinnamon rat, and the toxic milk mutant mouse. 13, 71 The blood ceruloplasmin level is decreased in Wilson's disease and its animal models as a result of faulty protein synthesis due to lack of copper transport into the cytomembrane network of the hepatocyte. Although ceruloplasmin is thought to be the major form in which extrahepatic tissues receive copper, other mechanisms of copper transport must exist because human patients with genetic aceruloplasminemia have normal tissue levels of copper. 11 The second possible fate of hepatocyte copper is incorporation into cuproproteins for use by the hepatocyte. Little is known of these synthetic pathways or their role in overall copper homeostasis. The studies utilizing one-celled organisms and studies reporting the various mutations in the Menkes' gene suggest specific, different copper transport pathways for the synthesis of each individual cuproenzyme. 2, 13, 39, 71 Thus, the various clinical signs found associated with the different mutations in the Menkes' gene (ATPase7A) are postulated to relate to the interruption of a specific synthetic pathway of various different cuproenzymes. And the variety of tissue defects in these individuals reflects the importance of particular cuproenzymes to the specific function(s) of the individual tissue/organ. 2, 11, 13, 71 A third possible fate for the copper within the hepatocyte is incorporation into MT. Metallothionein is a low molecular weight, metal-binding protein that is characterized by a high cysteine content. 10, 42, 43 It was first discovered as a cadmium-binding protein in equine renal cortex. The protein is ubiquitous; similar molecules have been identified in a broad range of species and in many different tissues and cell types. In the human genome, there are several MT genes, 42 whereas in dogs, two major isoforms of hepatic MT occur. 34, 41 MT gene transcription can be induced by various heavy metals, including copper, several different hormones, and physiological stress. 10 Because of MT's unique cysteine content, it has a high affinity for metals such as copper, zinc, and cadmium. Hepatic MT plays a fundamental role in trace mineral homeostasis and in the detoxification of heavy metals and is involved in the scavenging of free radicals. 42, 54 Normal dogs have a very high hepatic MT content relative to most species. 30 One might expect a simple correlation between hepatic copper and hepatic MT because dogs normally have a much higher hepatic copper concentration than do other species. However, the hepatic MT content of dogs is equal to that of humans, and humans have an hepatic copper concentration 15-20 times less than that normally found in dogs. 30 The high MT content of normal canine liver is unexplained.
A final pathway for hepatocyte copper is excretion into the bile. The biliary system is the major route of excretion of copper from the body. Several pathways in the hepatocyte have been shown to contribute copper to the biliary pool, including lysosomal exocytosis of copper into the bile, 21, 23, 40 nonlysosomal cytoplasmic vesicular transport, 40 transmembrane copper transport systems involving glutathione, 4 and transmembrane copper transport ATPases that are independent of glutathione. 14, 15 Biochemical evidence has not yet singled out a predominant excretory pathway for hepatocyte copper. However, the pathological accumulation of hepatic copper in Wilson's disease and its animal models, all of which are associated with absence of the transmembrane copper transport protein ATPase7B, suggests this route as a major component of the normal copper excretory pathway in the hepatocyte. 13, 71 
Normal hepatic copper concentration in dogs
What exactly the ''normal'' hepatic copper concentration is for a dog is far from clear. The dog appears to be an exception among animals. A number of stud-ies have shown that a mean hepatic copper concentration with a relatively narrow range can be used to characterize normal individuals of a species. Hepatic copper concentration is 15-20 parts per million on a dry weight basis (ppm dw) in horses, 51, 55 15-20 ppm dw in rats, 25, 49 15-20 ppm dw in mice, 6, 33, 42 100-150 ppm dw in cats, 16 and 10-30 ppm dw in humans. 42, 48 Such a narrow range is not true for dogs.
Keen et al., 38 in a study of laboratory beagles, reported a mean hepatic copper concentration of 300 ppm dw, with a range of 150-500. Reports on the copper storage disease of Bedlington terriers and West Highland white terriers used laboratory mongrels as the control group and reported the mean hepatic copper value of 200 as normal, with a range up to 400 ppm dw. 44, 70, 73 A subsequent publication, 69 detailing liver copper concentration and histological changes among 623 clinically normal dogs of various breeds, revealed a continuous spectrum of hepatic copper values ranging from less than 100 ppm dw to 6,800 ppm dw. An acceptable normal value could not be deduced from those data. 69 Even though no normal value could be decided upon, two facts should be considered when interpreting a quantitative copper determination in any breed except the Bedlington terrier. First, although dogs with liver copper concentration as high as 3,500 ppm dw with normal alanine aminotransferase and normal liver histology have been reported, 70 two studies demonstrated that no hepatitis (morphological diagnosis) was found in liver tissue containing less than 2,000 ppm dw. 69, 73 Second, only Bedlington terriers have been shown to continuously accumulate copper throughout life. 73 The only other breed studied extensively is the West Highland white terrier, and copper accumulation among this breed does not correlate with age. 69 In light of these two facts, liver copper concentration less than 2,000 ppm dw appears to have no adverse effect on the dog's health. Therefore, the closer the value is to 2,000 ppm dw and the younger the dog is, the more likely it is that the dog will suffer liver damage. Because of these facts, dogs with a quantitative value greater than 2,000 need to be treated (at least for a period of time) for the excess of copper.
Copper deficiency diseases in dogs
Body copper content (as measured by liver copper content) can be influenced by a variety of dietary factors, including molybdenum, calcium, sulfur, and zinc. In excess, these elements have been shown to reduce hepatic copper in some species, primarily ruminants, and cause a copper deficiency state. 42 Only one published report indicates that high levels of oral zinc have an effect of lowering the hepatic copper in normal beagle dogs. 75 Naturally occurring copper deficiency has not been identified as a significant cause of disease in dogs. This probably relates to the monogastric digestive system of the dog and the ubiquitous distribution of copper in foodstuffs. However, over the years, copper deficiency in dogs has been reported twice. 22, 24 Neither report is convincing that copper deficiency was the cause of the clinical disease. In both reports, the diagnosis was based upon a very low hepatic copper concentration measured by atomic absorption analysis.
In the two reports, 22, 24 the clinical signs were not suggestive of copper deficiency. For one dog, 24 the erythrocytic indices were normal, and the bone lesions reported were characteristic of fibrous osteodystrophy rather than copper deficiency. 5 Three puppies in the other report had acute illness and death. And one of them had an hepatic copper concentration of 5.8 ppm dw, a value characteristic of copper deficiency. 22 However, the puppies were from a large kennel with a reportedly good nutritional status, and the author even reported normal growth rates for the three puppies. The significance of the low hepatic copper in the puppy was not determined.
Lethal acrodermatitis of bull terriers 74 and chondrodysplasia of (dwarf) Alaskan malamutes 8 have both been suggested as possible syndromes of genetic copper deficiency. The lethal acrodermatitis of bull terriers is an autosomal recessive trait, but the defective protein/gene has not been identified. Affected dogs have growth retardation, chronic dermatitis, diarrhea, pneumonia, and abnormal behavior. Diseased dogs have decreased serum and hepatic levels of zinc and copper. 74 However, analytical data are limited. Although low serum copper values were reported for six affected dogs, low hepatic copper concentration was reported for only one affected dog. Interestingly, the control dogs (two) had hepatic copper concentrations of only 127.7 and 117.9 ppm dw, and the affected dog had a liver copper concentration of 68.3 ppm dw (assuming approximately 66% moisture; original report is nanomoles per gram, presumably wet weight). Even though a statistically significant difference was found between control and affected dogs, the single affected dog was not remarkably low when compared with other published studies. 69 The disease that causes the dwarf Alaskan malamutes has been compared to Menkes' disease. 61 This affliction in people was originally characterized as an inherited connective tissue disorder. However, the connective tissue manifestations have subsequently been shown to be secondary to an inherited defect in copper transport with resulting defects in the synthesis of cuproenzymes. 42 The studies in the dwarf Alaskan malamutes have shown reduced uptake in the blood of orally administered copper and alterations in collagen types I and III. These abnormalities are consistent with Menkes' disease. 8, 31, 42, 61 However, there are some differences between the affected dogs and Menkes' disease. The affected malamutes had an elevated hepatic copper, whereas people with Menkes' disease have decreased hepatic copper. 13, 71 Also, the disease in dogs is an autosomal recessive trait, whereas Menkes' is Xlinked. 8, 13, 71 Copper overload diseases in dogs Two methods have been used to assess the hepatic copper status of dogs, histochemistry and atomic absorption analysis. Two papers documented the use of histochemistry to provide a semiquantitative copper evaluation in the morphologically normal liver sample. Rubeanic acid and rhodanine were used to demonstrate the copper-loaded lysosomes in the canine liver, with the microwave rhodanine method being the quicker of the two. 35, 63 No copper-loaded lysosomes are visible with the histochemical methods until the hepatic copper concentration exceeds 400 ppm dw. 63 The histochemical methods are useful under certain circumstances but are only qualitative and do not provide the accuracy that atomic absorption analysis provides. Fresh, frozen, or formalin-fixed canine liver tissue provides reliable results with atomic absorption analysis. 63 The data that establish excess copper as a cause of canine liver disease are also sparse. The most convincing data are the studies of Bedlington terriers. 44, 59, 60, 73 This breed is afflicted with an autosomal recessive defect in copper metabolism. 36, 59, 60 Homozygous recessive individuals accumulate excess hepatic copper, with values rising as high as 10,000 ppm dw. Investigations have shown that the excess copper accumulates in essentially all cellular compartments of the hepatocyte. 34, 37, 41 Pathological changes have been described in both the cytoplasm and the nucleus of the copper-loaded hepatocytes. 27, 72 Affected individuals may suffer sudden death caused by acute hepatic necrosis or may suffer cirrhosis due to chronic hepatitis. 73 The protein/gene defect in Bedlington terriers is unknown, and the metabolic derangement of affected dogs has been only broadly characterized. 59, 60 Affected Bedlington terriers have a reduced copper excretion into the bile and increased hepatic and renal copper. 59, 60 In the hepatocyte, the lysosomes contain the largest percentage of the excess copper. The copper-engorged lysosomes preferentially accumulate in the cytoplasm of the zone 3 hepatocytes. 35, 44, 73 The copper is largely bound to MT within the lysosomes, but the inherited defect does not involve abnormal amino acid sequence of the two major MT isoproteins that occur in dogs. The same studies showed that the disease in not due to an abnormality (increase) in translation of the MT genes. 34 The increase in MT appears to be a secondary event in these dogs as it is in Wilson's disease. 13, 71 A few older Bedlingtons have been found with increased copper levels in the brain and cornea. 60 However, these latter findings are apparently a secondary phenomenon because younger affected dogs have normal brain and cornea copper levels concomitant with elevated hepatic and renal copper. 60 Whether the elevated renal copper concentration in affected dogs is secondary to the copper accumulation in the liver or is due to an effect of the abnormal gene in the renal epithelium is not clear.
Although the defective gene in Bedlington terriers has not yet been identified, a satellite marker is in use for early diagnosis. 32, 76 One report has indicated that the defective gene in the Bedlington terrier is not the same ATPase7B gene that is the cause of Wilson's disease in people. 7 The early publications on Bedlington terriers reported that homozygous recessive (affected) dogs could be clearly separated from heterozygous and homozygous normal dogs by quantitative copper determination. 36, 73 However, one proven heterozygote with an elevated hepatic copper concentration her entire lifetime has been reported. 62, 69 Her liver copper concentration was 1,100 ppm dw when she died of cancer at age 6.5 years. Figure 1 includes this dog and is an extended pedigree of that published earlier. 62 This pedigree clearly documents proven carrier dogs with hepatic copper concentration greater than 400 ppm dw.
A tabulation has been published of Bedlington terriers of various ages that form a numerical continuum similar to the data for West Highland white terriers (although this did not prove that all of the Bedlingtons with the modest levels were carriers). 69 Moreover, Bedlington terrier crossbreeds (proven heterozygous individuals) have a modest elevation in the hepatic copper concentration. 44 Taken together, these results suggest that the discrete cutoff point of 400 ppm dw that is said to separate homozygous recessive Bedlington terriers (affected) from heterozygous carriers apparently does not exist as originally described. 36, 73 Another interesting group of Bedlingtons has been observed. Figure 2 demonstrates a large family of Bedlington terriers, many of which had an obvious elevation in the hepatic copper concentration but none of which suffered liver disease. None of these dogs was ever treated with chelating agents or zinc. All of these dogs died in old age with histologically normal liver tissue at the time of death. When hepatic copper values as high as 10,000 ppm dw are reported for 4-6-yearold Bedlingtons, 73 the dogs in Fig. 2 are very unusual because of the relatively modest copper values and normal liver histology in light of their age. These dogs may represent carriers as reported previously 62, 69 or may represent a less serious form of the disease (different mutation?).
One observation from the early reports on Bedlington terriers was never explained. That observation was the trend for decreasing hepatic copper level for af-fected dogs after a peak around 6 years of age. 44, 73 Three possible explanations are available for this phenomenon. First, cirrhosis is a common outcome of copper toxicosis. 73 Possibly the proliferation of scar tissue during the development of cirrhosis dilutes the hepatocyte copper, resulting in an apparent decrease in hepatic copper concentration as discussed elsewhere. 64 A second possible explanation for the phenomenon is hepatocyte adaptation, as has been shown with chronic copper loading in rats and in the toxic milk mutant mouse. 6, 25, 28 Among rats fed a constant dietary copper excess (3,000 mg/kg), the hepatic copper levels reached an early peak (4,780 Ϯ 636 g/g), then fell significantly by the sixth week of the experiment (2,412 Ϯ 72 g/g). The decreasing copper level in the rats correlated with the time of the most severe hepatic necrosis and consequent hepatocyte regeneration. It is interesting that the regenerated hepatocytes (after massive necrosis) failed to accumulate copper. This same phenomenon has been reported for the cirrhotic liver of older affected mice of the toxic milk mutant strain, which is a model of Wilson's disease. 6, 25, 28 In the cirrhotic liver of a Bedlington terrier (or any other breed of dog where the cirrhotic liver has increased copper), one can easily separate the regenerated hepatocyte nodules from the remaining undisturbed parenchyma in sections stained to demonstrate copper. The hepatocytes of the regenerative nodules in the cirrhotic dog liver do not contain copper granules. Apparently, the same adaptive mechanism that was demonstrated in the liver of the copper-loaded rats and toxic milk mutant mouse operates in the liver of Bedlington terriers (and other breeds) during regeneration after an episode of hepatic necrosis. This adaptation may explain the decreased hepatic copper concentrations in older affected Bedlington terriers.
The third consideration that could explain the decreased hepatic copper concentration in older affected Bedlingtons could be a reflection of the normal homeostatic regulatory mechanism shown to operate in the fetal liver of humans, 42 rats, 42 mice, 6 horses, 17 and guinea pigs. 58 In these species, the hepatic copper reaches a peak in late gestation or in the postnatal period and subsequently decreases to adult levels. The hepatic copper concentration in the liver of dogs increases from fetal levels through neonatal levels and finally reaches adult levels by 2-4 weeks after birth. 50 The suggestion has been made that the fetal accumulation provides the copper stores necessary for the neonatal period because milk is a poor source of copper. The lower ''adult'' copper concentration characteristic of most species is reached shortly after birth when dietary sources of copper become adequate. The regulatory mechanism that is responsible for the switch from the fetal hepatic copper level to the adult level is unknown. Table 1 is a listing of West Highland white terriers that had two liver biopsies several years apart. The initial biopsy was collected because the owners were concerned about copper toxicosis. With the exception of dog no. 1, the second sample was collected at the time of death. None of the dogs in Table 1 was treated with zinc or a chelator, yet dog nos. 7-14 had a marked decrease in hepatic copper over the course of their lifetime. Dog nos. 7-14 in Table 1 and the dogs in Fig.  2 may represent the same regulatory mechanism in copper homeostasis as demonstrated in the other species, although the regulatory mechanism may have become operative much later in life in the case of these select dogs.
The role of copper in the causation of liver disease in breeds of dogs other than the Bedlington terrier is less clear ( Table 2 ). Elevated hepatic copper (i.e., greater than 400 ppm dw) has been reported to occur in the liver tissue of clinically normal dogs 62, 69, 70 as well as in diseased liver from breeds other than Bedlington terriers. And hepatic copper concentrations as high as those reported for the most severely affected Bedlingtons have been reported in West Highland white terriers, 69, 70 Skye terriers, 2, 9 a dalmatian, 9 keeshonds, 62 and Doberman pinschers. 65 Once the hepatic concentration surpasses 400 ppm dw, the excess hepatic copper begins to accumulate within lysosomes in all breeds of dogs. 35, 63, 69 Moreover, the excess copper is first demonstrable within the hepatocytes of zone 3. 35, 44, 63, 69, 73 Then, as the copper concentration increases further, the zone of hepatocytes with histochemically demonstrable copper granules expands to involve the cells in zone 2. Finally, at the highest hepatic copper concentrations, even the zone 1 hepatocytes contain copper-positive granules. This distribution is contrary to that found in the liver of copper-loaded animals of other species. 18 Only the Bedlingtons have been shown to accumulate copper continuously throughout life. 73 The only other breed studied extensively is the West Highland white terrier. 64, 69, 70 The initial studies in Westies failed to find a correlation between age and hepatic copper concentration, indicating that this breed did not continuously accumulate copper throughout life. 69 However, Table 1 is a list of 14 Westies that had two biopsies in their lifetime. None of the dogs was treated with zinc or a chelating agent. These dogs formed three groups. Dog nos. 1-4 accumulated copper with age, dog nos. 5 and 6 remained at the same level throughout life, and dog nos. 7-14 showed a decrease in copper as they aged. The phenomenon is not yet explained.
The published reports of liver disease associated with increased hepatic copper in various breeds of dogs include acute hepatic necrosis, 9 subacute hepatitis, 57,64,65,68 chronic hepatitis, 12, 29, 65 and cirrhosis. 12, 62, 65, 66 In two of these studies, 64, 69 the histopathology of the diseased liver was the same as that described in the Bedlington terrier. 44, 73 These data indicate that excess * This biopsy was collected because the dog was clinically ill and had elevated alanine aminotransferase (ALT) on biochemical profile. The dog was never treated for the excess copper. The dog was alive and well in January 1999 and the ALT was normal.
† Daughter of dog no. 11. Table 2 . Important facts regarding copper accumulation in the canine liver.
1. Several breeds of dogs accumulate hepatic copper in excess of 400 ppm dw* in the absence of liver disease. This phenomenon occurs in families of dogs. 2. The serum copper level is within the normal range regardless of the hepatic copper concentration. 3. Copper does not cause hepatitis at concentrations below 2,000 ppm dw. However, dogs may accumulate as much as 3,500 ppm dw before liver disease occurs. 4. Histochemical methods can be used as a qualitative method to demonstrate copper-loaded lysosomes in the canine liver when the hepatic copper concentration exceeds 400 ppm dw. The copper-loaded hepatocytes will be in zone 3 (around the central vein). 5. Atomic absorption analysis with fresh, frozen, or formalin-fixed liver tissue is the only way to accurately assess the hepatic copper concentration.
* ppm dw ϭ parts per million dry weight.
hepatic copper is a cause of hepatitis in other breeds of dogs. 64, 69 Over the years, three considerations have been put forth to explain the elevated hepatic copper in these other breeds of dogs. The first suggestion is that the excess copper is the result of an inherited metabolic defect that is similar to, or may even be a variation of, the disease of Bedlington terriers. Another suggestion has been that the copper accumulates as a consequence of altered bile flow (cholestasis) caused by chronic liver fibrosis and cirrhosis. The third suggestion is that the excess copper accumulation could be the result of the relatively high copper content of commercial dog food.
The idea of an inherited genetic defect that is widespread among several breeds of dogs has received the most support. Several reports have documented copper accumulation in the liver in the absence of any hepatic disease. 62, 69, 70 These reports substantiate that elevated hepatic copper can occur prior to the onset of chronic liver disease in numerous breeds other than Bedlingtons. Two reports document familial relationships among dogs with increased hepatic copper. 62, 70 However, genetic analysis of those data 69, 70 could not be performed because of the lack of an unequivocal quantitative value that could be used to distinguish between ''normal'' and ''abnormal,'' as discussed above. Also, no breeding experiments have been published.
Copper accumulation secondary to cholestasis has been mentioned several times in the literature as a cause of copper accumulation in dogs with chronic hepatitis or cirrhosis. 12, 29 In dogs, this is pure speculation that is based upon the phenomenon that is well documented to occur among people with chronic (years) biliary disease or cirrhosis. 48 Sequential biopsies or experimental work has never shown that dogs accumulate excess hepatic copper secondary to bile duct obstruction or chronic hepatitis. In fact, a decrease in hepatic copper as the cirrhosis progressed has been documented. 67 Finally, the excess copper found in the canine liver could be the result of the relatively high copper content of commercial dog food. 44, 60 The minimal daily copper requirement for the dog is 0.06 mg/kg/day. 47 Commercial dog foods are relatively high in copper content when compared with this recommendation, ranging from 12 to 16 mg/kg dry matter. 52 The daily intake for a 10-kg dog, consuming a recommended portion of a standard commercial dog food, 52 is 3 mg copper/day. This value is somewhat above both the 1.6-mg daily intake that has been shown to maintain normal liver copper levels in that same 10-kg dog 38 and the minimal recommended daily intake of 0.6 mg. 47 No chronic copper loading experiments in dogs have been published. Therefore, the toxic level of orally ingested copper for dogs is not known. Consequently, evaluation of the exact effect of the copper concentration in commercial dog foods is virtually impossible. However, in published reports on other monogastric species, approximately 200 ppm dw copper in the diet is necessary to produce elevated hepatic copper (pigs, rats, and horses). 1, 26, 45, 56 In the reports on toxicity, the experimental dietary concentrations are considerably above the 12-16 ppm dw found in commercial dog foods. 52 As a note, the maximum allowable copper concentration in dog foods is 250 ppm dw, and this is based upon the concentration that is toxic to swine. 3 In one study that included 395 West Highland white terriers, approximately 40% of the dogs had hepatic copper concentration less than 500 ppm dw. 69 Yet, all of those 395 dogs were on one form or another of commercial dog food. The range in hepatic copper concentration among those 395 West Highland white terriers (less than 100 up to 6,800 ppm dw) could not be attributed to diet alone. The one conclusion that seems obvious is that commercial dog food alone is not sufficient to produce an elevated hepatic copper concentration and cause liver disease in dogs.
Conclusions
The first publications on Bedlington terriers appeared to document a genetic disease that was unique to that breed of dogs. 36, 44, 73 The idea put forth was that all homozygous recessive dogs died because of copper toxicosis, and heterozygous carriers all had a copper level less than 400 ppm dw. Subsequent to those publications, investigators have not only expanded the observations on Bedlington terriers but have provided details on hepatic copper concentrations in a variety of breeds. As a whole, the observations have provided four ideas. First, hepatic copper accumulates in several breeds of dogs to values as high as those reported to occur in Bedlington terriers. 9, 12, 62, 65, 66, 69, 70 Second, this copper accumulation can occur in the absence of any hepatic pathology. 69 Third, the hepatic distribution of the excess copper within the liver is identical among all of the breeds of dogs (i.e., zone 3) and different from that of other copper-loaded species (i.e., zone 1). 18, 35, 65, 69, 70 Finally, hepatic pathology does not occur at copper values less than 2,000 ppm dw, although even higher values can be found in some dogs with normal liver histology, as seen, for example, in Fig.  2 . 69, 70, 73 None of the reports has found a numerical value that will clearly specify normal hepatic copper concentration for a dog. Quantitatively, the hepatic copper values in a large group of West Highland white terriers (and probably in all breeds) form a continuous numerical spectrum up to 6,800 ppm dw. 69 Some carriers among the Bedlington terriers have elevated hepatic copper concentration ( Fig. 1 ), 62 and Bedlington terriers, like other breeds, can be lined up to form a quantitative numerical spectrum that bridges the traditional normal value of 400 ppm dw. 69 The differences between Bedlington terriers and dogs from other breeds identified by increased hepatic copper are blurred.
Regarding Bedlington terriers, the unusual carrier with elevated hepatic copper appears to be rare. Therefore, until a definitive genetic test is available, it is useful to assume that a copper value in the range of 2,000 ppm dw or greater in a Bedlington terrier older than 1 year will identify the homozygous recessive (affected) dog. Under these circumstances, the diagnosis should serve as the basis for institution of lifelong chelation or zinc therapy.
